DemDx announced as NHS Innovation Accelerator
The NHS Innovation Accelerator (NIA) today announced DemDx as one of 10 promising innovations that will be supported to spread across England’s NHS over the next three years. DemDx is a CE marked AI clinical reasoning platform which supports frontline healthcare practitioners’ clinical assessments at the first point of patient contact. It helps meet the capacity and operational challenges faced by primary and acute care providers, while making considerable efficiencies across the whole patient care journey.
The 2022 cohort of innovations – and their representative innovators (‘Fellows’) – were selected through a robust, multi-stage application and assessment process involving a college of expert clinical, patient and commercial assessors. This panel was drawn from a wide range of organisations, including NHS England and NHS Improvement, AHSNs, the National Institute for Health and Care Excellence (NICE) and The Health Foundation.
The announcement marks the seventh cohort of Fellows since the NIA was launched in 2015. The national accelerator is commissioned by the Accelerated Access Collaborative at NHS England and NHS Improvement. It is delivered in partnership with the 15 Academic Health Science Networks (AHSNs), hosted by UCLPartners, and chaired by Professor Stephen Powis, National Medical Director for NHS England and NHS Improvement.
Lorin Gresser, DemDx Chief Executive, says:
“DemDx addresses one of the NHS’s most pressing issues: the shortage of front-line clinical staff. DemDx supports non-doctor frontline clinicians to take on more clinical responsibility, safely and with confidence, during that most critical first point of contact clinical assessment.
We are delighted to be selected as part of the NHS Innovation Accelerator 2022 cohort and look forward to working with our clinical partners to deploy our innovation at scale across the NHS.”
Note to Editors
DemDX is an AI-enhanced Clinical Reasoning Platform that supports frontline healthcare professionals to diagnose, order investigations and make care recommendations at the first point of contact, before the patient sees a doctor.
The full transparent medically-certified platform is the only such licensed tool available to frontline practitioners in their clinical assessments, built on a database developed by over 100 doctors covering 15 specialities, over 2,800 diagnoses with more than 1.5m clinical pathways.
For more information about DemDX, please visit https://demdx.com/ or follow @Dem_Dx on Twitter
About the NIA
The NHS Innovation Accelerator (NIA) is an award-winning NHS England initiative delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs), hosted at UCLPartners. It supports delivery of the NHS Long Term Plan priorities by accelerating uptake of high impact innovations for patient, population and NHS staff benefit, and providing practical insights on spread to inform national strategy.
Since it launched in July 2015, the NIA has supported 60 Fellows representing 62 innovations. Over 2,210 additional NHS sites are now using NIA innovations, £134.8m external funding has been raised, 468 jobs created, 113 awards won, and 45 NIA innovations are selling internationally.